Global Influenza Daignostic Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Influenza Daignostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Rapid Flu Detection Test
  • 1.3.3 Virus Detection
  • 1.3.4 Direct Fluorescent Antibody (DFA) Test
  • 1.3.5 Serological Testing
• 1.4 Market by Application
  • 1.4.1 Global Influenza Daignostic Market Share by Application: 2020 VS 2026
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Influenza Daignostic Market Perspective (2015-2026)
• 2.2 Influenza Daignostic Growth Trends by Regions
  • 2.2.1 Influenza Daignostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Influenza Daignostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Influenza Daignostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Influenza Daignostic Industry Dynamic
  • 2.3.1 Influenza Daignostic Market Trends
  • 2.3.2 Influenza Daignostic Market Drivers
  • 2.3.3 Influenza Daignostic Market Challenges
  • 2.3.4 Influenza Daignostic Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Influenza Daignostic Players by Market Size
  • 3.1.1 Global Top Influenza Daignostic Players by Revenue (2015-2020)
  • 3.1.2 Global Influenza Daignostic Revenue Market Share by Players (2015-2020)
• 3.2 Global Influenza Daignostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Influenza Daignostic Revenue
• 3.4 Global Influenza Daignostic Market Concentration Ratio
  • 3.4.1 Global Influenza Daignostic Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Influenza Daignostic Revenue in 2019
• 3.5 Key Players Influenza Daignostic Area Served
• 3.6 Key Players Influenza Daignostic Product Solution and Service
• 3.7 Date of Enter into Influenza Daignostic Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Daignostic Breakdown Data by Type

• 4.1 Global Influenza Daignostic Historic Market Size by Type (2015-2020)
• 4.2 Global Influenza Daignostic Forecasted Market Size by Type (2021-2026)

5 Influenza Daignostic Breakdown Data by Application

• 5.1 Global Influenza Daignostic Historic Market Size by Application (2015-2020)
• 5.2 Global Influenza Daignostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Influenza Daignostic Market Size (2015-2026)
• 6.2 North America Influenza Daignostic Market Size by Type (2015-2020)
• 6.3 North America Influenza Daignostic Market Size by Application (2015-2020)
• 6.4 North America Influenza Daignostic Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Influenza Daignostic Market Size (2015-2026)
• 7.2 Europe Influenza Daignostic Market Size by Type (2015-2020)
• 7.3 Europe Influenza Daignostic Market Size by Application (2015-2020)
• 7.4 Europe Influenza Daignostic Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Influenza Daignostic Market Size (2015-2026)
• 8.2 Asia-Pacific Influenza Daignostic Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Influenza Daignostic Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Influenza Daignostic Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Influenza Daignostic Market Size (2015-2026)
• 9.2 Latin America Influenza Daignostic Market Size by Type (2015-2020)
• 9.3 Latin America Influenza Daignostic Market Size by Application (2015-2020)
• 9.4 Latin America Influenza Daignostic Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Influenza Daignostic Market Size (2015-2026)
• 10.2 Middle East & Africa Influenza Daignostic Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Influenza Daignostic Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Influenza Daignostic Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Influenza Daignostic Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in Influenza Daignostic Business (2015-2020))
  • 11.1.5 Thermo Fisher Scientific Recent Development
• 11.2 Abbott Laboratories
  • 11.2.1 Abbott Laboratories Company Details
  • 11.2.2 Abbott Laboratories Business Overview
  • 11.2.3 Abbott Laboratories Influenza Daignostic Introduction
  • 11.2.4 Abbott Laboratories Revenue in Influenza Daignostic Business (2015-2020)
  • 11.2.5 Abbott Laboratories Recent Development
• 11.3 Danaher Corporation
  • 11.3.1 Danaher Corporation Company Details
  • 11.3.2 Danaher Corporation Business Overview
  • 11.3.3 Danaher Corporation Influenza Daignostic Introduction
  • 11.3.4 Danaher Corporation Revenue in Influenza Daignostic Business (2015-2020)
  • 11.3.5 Danaher Corporation Recent Development
• 11.4 Bio-Rad Laboratories
  • 11.4.1 Bio-Rad Laboratories Company Details
  • 11.4.2 Bio-Rad Laboratories Business Overview
  • 11.4.3 Bio-Rad Laboratories Influenza Daignostic Introduction
  • 11.4.4 Bio-Rad Laboratories Revenue in Influenza Daignostic Business (2015-2020)
  • 11.4.5 Bio-Rad Laboratories Recent Development
• 11.5 BIOMÉRIEUX
  • 11.5.1 BIOMÉRIEUX Company Details
  • 11.5.2 BIOMÉRIEUX Business Overview
  • 11.5.3 BIOMÉRIEUX Influenza Daignostic Introduction
  • 11.5.4 BIOMÉRIEUX Revenue in Influenza Daignostic Business (2015-2020)
  • 11.5.5 BIOMÉRIEUX Recent Development
• 11.6 Roche
  • 11.6.1 Roche Company Details
  • 11.6.2 Roche Business Overview
  • 11.6.3 Roche Influenza Daignostic Introduction
  • 11.6.4 Roche Revenue in Influenza Daignostic Business (2015-2020)
  • 11.6.5 Roche Recent Development
• 11.7 Becton Dickinson And Company
  • 11.7.1 Becton Dickinson And Company Company Details
  • 11.7.2 Becton Dickinson And Company Business Overview
  • 11.7.3 Becton Dickinson And Company Influenza Daignostic Introduction
  • 11.7.4 Becton Dickinson And Company Revenue in Influenza Daignostic Business (2015-2020)
  • 11.7.5 Becton Dickinson And Company Recent Development
• 11.8 Meridian Bioscience
  • 11.8.1 Meridian Bioscience Company Details
  • 11.8.2 Meridian Bioscience Business Overview
  • 11.8.3 Meridian Bioscience Influenza Daignostic Introduction
  • 11.8.4 Meridian Bioscience Revenue in Influenza Daignostic Business (2015-2020)
  • 11.8.5 Meridian Bioscience Recent Development
• 11.9 Quidel Corporation
  • 11.9.1 Quidel Corporation Company Details
  • 11.9.2 Quidel Corporation Business Overview
  • 11.9.3 Quidel Corporation Influenza Daignostic Introduction
  • 11.9.4 Quidel Corporation Revenue in Influenza Daignostic Business (2015-2020)
  • 11.9.5 Quidel Corporation Recent Development
• 11.10 Hologic
  • 11.10.1 Hologic Company Details
  • 11.10.2 Hologic Business Overview
  • 11.10.3 Hologic Influenza Daignostic Introduction
  • 11.10.4 Hologic Revenue in Influenza Daignostic Business (2015-2020)
  • 11.10.5 Hologic Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer